MLN7243
C33001
Phase 1 small_molecule terminated
Quick answer
MLN7243 for Advanced Malignant Solid Tumors is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Advanced Malignant Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated